PhD Dolors Colomer
Hospital Clinic, University of Barcelona
Hematopathology SectionLaboratory of Pathology
Contact
Villarroel 170
E-08036 Barcelona
E-08036 Barcelona
Literature
- Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia
Authors: Giménez N, Schulz R, Higashi M, Aymerich M, Villamor N, Delgado J, Juan M, López-Guerra M, Campo E, Rosich L, Seiffert M, Colomer D.
Reference: LEUKEMIA 2020; 34(1):100-114. - Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia
Authors: Lee-Vergés E, Hanna BS, Yazdanparast H, Rodríguez V, Rodríguez ML, Giró A, Vidal-Crespo A, Rosich L, Amador V, Aymerich M, Villamor N, Delgado J, Lichter P, Pérez-Galán P, López-Guerra M, Campo E, Seiffert M, Colomer D.
Reference: INTERNATIONAL JOURNAL OF CANCER 2019; 144(11):2762-2773. - Control of chronic lymphocytic leukemia development by clonally-expanded CD8+T-cells that undergo functional exhaustion in secondary lymphoid tissues
Authors: Hanna B., Roessner P., Yazdanparast H., Colomer D., Campo E., Kugler S., Yosifov D., Stilgenbauer S., Schmidt M., Gabriel R., Lichter P., Seiffert M..
Reference: LEUKEMIA 2019; 33(3):625-637.